Ernexa Therapeutics (ERNAW) Return on Capital Employed Growth (1y) (2012 - 2026)
Ernexa Therapeutics (ERNAW) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
31,429.00 |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
16,829.00 |
| 10 |
Ernexa Therapeutics |
- |
- |
- |
-49,661.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-49,661.00 |
| Dec 31, 2025 |
11,842.00 |
| Sep 30, 2025 |
-10,029.00 |
| Jun 30, 2025 |
-22,038.00 |
| Mar 31, 2025 |
29,113.00 |
| Dec 31, 2024 |
-39,293.00 |
| Sep 30, 2024 |
-5,898.00 |
| Jun 30, 2024 |
3,882.00 |
| Mar 31, 2024 |
19,071.00 |
| Dec 31, 2023 |
19,023.00 |
| Sep 30, 2023 |
17,468.00 |
| Jun 30, 2023 |
38,266.00 |
| Mar 31, 2023 |
13,065.00 |
| Dec 31, 2022 |
11,970.00 |
| Sep 30, 2022 |
120.00 |
| Jun 30, 2022 |
-41,254.00 |
| Mar 31, 2022 |
-25,579.00 |
| Dec 31, 2021 |
-23,405.00 |
| Mar 31, 2021 |
-8,633.00 |
| Dec 31, 2020 |
-10,288.00 |
